NCT03871790View on ClinicalTrials.gov

Peptide-based Immunization for Colon- and and Pancreas-carcinoma

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

April 1, 2022

Study Completion Date

August 31, 2022

Conditions

Colon NeoplasmColon AdenocarcinomaColon CancerColo-rectal CancerRectal CancerRectal NeoplasmsRectal AdenocarcinomaRectal TumorsPancreatic CancerPancreas CancerPancreatic NeoplasmsPancreatic Adenocarcinoma

Trial Locations (1)

Unknown

Teaching Hospital UOL Cancer Center, Lahore

All Listed Sponsors

lead

CENTOGENE GmbH Rostock

INDUSTRY

NCT03871790 - Peptide-based Immunization for Colon- and and Pancreas-carcinoma | Biotech Hunter | Biotech Hunter